Zarif Lab
News
The Zarif Lab at Johns Hopkins University is always exploring through research and innovation in identifying therapeutic targets, with an emphasis on M2 tumor-associated macrophages and metastatic prostate cancer. Find more information about our center areas, ongoing research, software, data, protocols and methods and other recent news.
Monali Praharaj selected as a 2022 AACR Scholar
Monali Praharaj was selected as a 2022 AACR Scholar in training travel award! She presented her work on targeting TAMs in urologic cancers!
Dr. Debebe completes his M.D./Ph.D.
Debebe completed his M.D./Ph.D. and graduated May 2022. He is now a Resident Physician in Neurosurgery at Stanford Health.
Mannose Receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses
The Zarif lab contributed to the article titled “Mannose Receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses” that was published in Science Translational Medicine
Raekwon Williams, MERIT and Ingenuity scholar, presents his research at the annual MERIT Symposium
Mr. Raekwon Williams, a Senior at Baltimore Polytechnic Institute and both MERIT and Ingenuity scholar presented his prostate cancer research generated in the lab at the annual MERIT Symposium.
Study Links M2 Macrophages to More Aggressive Prostate Cancer
The Zarif laboratory has recently published a manuscript titled “Mannose Receptor-positive Macrophage infiltration correlates with prostate cancer onset and metastatic castration-resistant disease” in European Urology Oncology. We found that CD206 expression increased in human castration resistant disease relative to normal prostatic tissues.